Previous Article | Next Article 
Infection and Immunity, January 2007, p. 497-503, Vol. 75, No. 1
0019-9567/07/$08.00+0 doi:10.1128/IAI.00935-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Hypothetical Protein Cpn0308 Is Localized in the Chlamydia pneumoniae Inclusion Membrane
Jianhua Luo,1
Tianjun Jia,1,2
Rhonda Flores,1
Ding Chen,1 and
Guangming Zhong1*
Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229,1
Department of Immunology, Hebei Medical University, Shijiazhuang, Hebei, China 0500172
Received 12 June 2006/
Returned for modification 16 August 2006/
Accepted 20 October 2006

ABSTRACT
The hypothetical protein encoded by
Chlamydia pneumoniae open
reading frame cpn0308 was detected in inclusion membranes of
C. pneumoniae-infected cells using antibodies raised with Cpn0308
fusion proteins. The anti-Cpn0308 antibodies did not cross-react
with IncA, a known
C. pneumoniae inclusion membrane protein,
although the anti-Cpn0308 antibody staining overlapped with
the anti-IncA antibody labeling. The labeling of the inclusion
membrane by the anti-Cpn0308 antibody was specifically blocked
by the Cpn0308 but not IncA fusion proteins. The Cpn0308 antigen
was detectable 24 h after infection and remained in the inclusion
membrane throughout the infection course.

TEXT
Although both
Chlamydia trachomatis and
C. pneumoniae are human
pathogens and share a common obligate intravacuolar biphasic
life cycle (
9,
10,
18), they differ in tissue tropism.
C. trachomatis primarily infects ocular and urogenital tissues, leading to
preventable blindness in some developing nations and becoming
a major cause of sexually transmitted bacterial diseases in
the developed world. The species
C. pneumoniae infects the human
respiratory tract. Although the respiratory infection with
C. pneumoniae is often asymptomatic in immune-competent individuals
(
8,
18), it is associated with pathologies in other systems,
including the cardiovascular system (
3,
4,
14,
16,
17,
19,
23).
The chlamydial ability to replicate inside a cytoplasmic vacuole
(designated inclusion) of host cells likely contributes to the
chlamydial pathogenicity (
2,
18). In order to establish and
maintain a successful intravacuolar growth,
Chlamydia has to
exchange both materials and signals with host cells via the
inclusion membrane. For example,
Chlamydia has possessed the
capacity of both importing nutrients and metabolic intermediates
from host cells (
5,
11,
12,
22,
26) and secreting chlamydial
factors into host cells (
6,
25,
29,
30). However, the pathways
that
Chlamydia organisms use to interact with host cells are
largely unknown. Since the first identification of
Chlamydia-encoded
proteins in the inclusion membrane (designated Inc proteins
[
20]), it has been hypothesized that the Inc proteins may either
participate in the transmission of signals and materials or
serve as effector molecules during chlamydial interactions with
host cells (
13,
21). Identification of Inc proteins may facilitate
our understanding of how
Chlamydia interacts with host cells.
Therefore, searching for novel inclusion membrane proteins has
become a hot topic under intensive investigation. We have recently
employed an anti-fusion protein antibody approach for identifying
new inclusion membrane proteins in
C. pneumoniae-infected cells
and found that the hypothetical protein Cpn0308 is localized
in the
C. pneumoniae inclusion membrane.
We expressed the hypothetical proteins encoded by open reading frames (ORFs) from the C. pneumoniae AR39 genome as fusion proteins with GST (glutathione-S-transferase) as the N-terminal fusion tag (24). Mice were immunized with the purified chlamydial fusion proteins to raise both polyclonal antisera (pAb) and monoclonal antibodies (MAb) (31). The mouse antibodies were used to localize the endogenous proteins in C. pneumoniae-infected cells via an indirect immunofluorescence assay (30). The antibodies raised against the Cpn0308 fusion protein labeled the C. pneumoniae inclusion membrane (Fig. 1). Both the anti-Cpn0308 pAb and MAbs consistently detected a dominant inclusion membrane signal similar to the signal revealed by the anti-IncA, but not the anti-CPAF, anti-MOMP, or anti-HSP60 antibodies. We further verified the inclusion membrane localization of Cpn0308 using confocal microscopy. The anti-Cpn0308 labeling did not colocalize with CPAF, MOMP, or HSP60 but clearly overlapped with the anti-IncA labeling, even at different focal points along the Z axis. IncA, encoded by the C. pneumoniae ORF cpn0186, is a known inclusion membrane protein in C. pneumoniae-infected cells (1, 15). The above observations have demonstrated that Cpn0308, like IncA, is also an inclusion membrane protein. We further used several approaches to confirm the antibody binding specificities. The anti-Cpn0308 MAbs reacted with the GST-Cpn0308 but not the GST-IncA or GST-CPAFcp fusion proteins, although all fusion proteins were detectable by their corresponding homologous antibodies (data not shown). The antibodies raised with the chlamydial GST fusion proteins were further reacted with the red fluorescence protein (RFP)-C. pneumoniae fusion proteins expressed in transfected cells. The anti-Cpn0308 antibodies detected the RFP-Cpn0308 but not the RFP-IncA fusion proteins (Fig. 2A). More importantly, the detection of the endogenous antigens in the C. pneumoniae-infected cells by the anti-Cpn0308 and anti-IncA antibodies was blocked by the corresponding homologous but not the heterologous GST fusion proteins in an immunofluorescence assay (Fig. 2B). Finally, a Western blot assay was carried out to further evaluate the anti-Cpn0308reactivity with the C. pneumoniae-infected cell lysates (Fig. 2C). The anti-Cpn0308 antibody only recognized a protein band corresponding to the endogenous Cpn0308 from the lysates of C. pneumoniae-infected HeLa cells but not HeLa cells alone or C. trachomatis-infected cells. Together, the above experiments have demonstrated that the anti-Cpn0308 antibody specifically detected the Cpn0308 antigen in the inclusion membrane of the C. pneumoniae-infected cells. When the expression of Cpn0308 protein was monitored along the infection time, Cpn0308 was first detected 24 h after infection and remained in the inclusion membrane throughout the infection course (Fig. 3).
In the current study, we have confirmed the localization of
IncA in the
C. pneumoniae inclusion membranes and, more importantly,
identified the hypothetical protein Cpn0308 as a novel inclusion
protein using both polyclonal antisera and monoclonal antibodies.
The antibodies raised against IncA and Cpn0308 both labeled
the
C. pneumoniae inclusion membranes. However, no cross-reactivity
was found between these two, which is consistent with the finding
that there is no significant amino acid sequence homology between
IncA and Cpn0308 (
http://www.ncbi.nlm.nih.gov/BLAST/BLAST.cgi).
Cpn0308 is a 133-amino-acid protein encoded by a hypothetical
ORF flanked by two known genes,
glgP (alpha glycan phosphorylase)
and
dnaA (DnaA replication protein;
http://www.stdgen.lanl.gov/),
in the
C. pneumoniae genome. Cpn0308 seems to be unique for
the
C. pneumoniae species, since no homologues are found in
any other chlamydia or non-chlamydia species by BLAST search
(
http://www.ncbi.nlm.nih.gov/BLAST/BLAST.cgi). It is not clear
why cpn0308 was not listed as a
C. pneumoniae-specific hypothetical
ORF (
http://www.stdgen.lanl.gov/). Despite the lack of primary
sequence homology, computer-based prediction programs did predict
Cpn0308 as an Inc protein (
28), and Cpn0308 was secretable in
a heterologous type III system (
27). We have now provided the
first experimental evidence directly demonstrating the localization
of Cpn0308 in the
C. pneumoniae inclusion membrane. Since not
all predicted inclusion membrane proteins are localized in the
inclusion membrane (
1) and not all experimentally demonstrated
inclusion membrane proteins were predicted by computer-based
methods (
1,
7,
21,
28), it is both necessary and significant
to experimentally search for new inclusion membrane proteins
in
Chlamydia-infected cells. Once sufficient inclusion membrane
proteins are identified, we may be able to more precisely unravel
the structural features of the inclusion membrane proteins and
further understand the functions of these proteins.

ACKNOWLEDGMENTS
This work was supported in part by grants (to G. Zhong) from
the National Institutes of Health.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229. Phone: (210) 567-1169. Fax: (210) 567-0293. E-mail:
Zhongg{at}UTHSCSA.EDU.

Published ahead of print on 13 November 2006. 
Editor: J. B. Bliska

REFERENCES
1 - Bannantine, J. P., R. S. Griffiths, W. Viratyosin, W. J. Brown, and D. D. Rockey. 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2:35-47.[CrossRef][Medline]
2 - Campbell, L. A., and C. C. Kuo. 2002. Chlamydia pneumoniae pathogenesis. J. Med. Microbiol. 51:623-625.[Medline]
3 - Campbell, L. A., and C. C. Kuo. 2004. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2:23-32.[CrossRef][Medline]
4 - Campbell, L. A., T. Nosaka, M. E. Rosenfeld, K. Yaraei, and C. C. Kuo. 2005. Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice. Infect. Immun. 73:3164-3165.[Abstract/Free Full Text]
5 - Carabeo, R. A., D. J. Mead, and T. Hackstadt. 2003. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. USA 100:6771-6776.[Abstract/Free Full Text]
6 - Fan, P., F. Dong, Y. Huang, and G. Zhong. 2002. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect. Immun. 70:345-349.[Abstract/Free Full Text]
7 - Fling, S. P., R. A. Sutherland, L. N. Steele, B. Hess, S. E. D'Orazio, J. Maisonneuve, M. F. Lampe, P. Probst, and M. N. Starnbach. 2001. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 98:1160-1165.[Abstract/Free Full Text]
8 - Grayston, J. T. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 43:317-323.[CrossRef][Medline]
9 - Hackstadt, T. 1998. The diverse habitats of obligate intracellular parasites. Curr. Opin. Microbiol. 1:82-87.[CrossRef][Medline]
10 - Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293.[CrossRef][Medline]
11 - Hackstadt, T., D. D. Rockey, R. A. Heinzen, and M. A. Scidmore. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977.[Medline]
12 - Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. USA 92:4877-4881.[Abstract/Free Full Text]
13 - Hackstadt, T., M. A. Scidmore-Carlson, E. I. Shaw, and E. R. Fischer. 1999. The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol. 1:119-130.[CrossRef][Medline]
14 - Hu, H., G. N. Pierce, and G. Zhong. 1999. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Investig. 103:747-753.[Medline]
15 - Kalman, S., W. Mitchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21:385-389.[CrossRef][Medline]
16 - Kuo, C. C., L. A. Campbell, and M. E. Rosenfeld. 2002. Chlamydia pneumoniae infection and atherosclerosis: methodological considerations. Circulation 105:E34.[Medline]
17 - Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, and E. P. Benditt. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92:6911-6914.[Abstract/Free Full Text]
18 - Kuo, C. C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.[Abstract]
19 - Liu, L., H. Hu, H. Ji, A. D. Murdin, G. N. Pierce, and G. Zhong. 2000. Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol. Cell Biochem. 215:123-128.[CrossRef][Medline]
20 - Rockey, D. D., R. A. Heinzen, and T. Hackstadt. 1995. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol. Microbiol. 15:617-626.[Medline]
21 - Rockey, D. D., M. A. Scidmore, J. P. Bannantine, and W. J. Brown. 2002. Proteins in the chlamydial inclusion membrane. Microbes Infect. 4:333-340.[CrossRef][Medline]
22 - Scidmore, M. A., E. R. Fischer, and T. Hackstadt. 1996. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J. Cell Biol. 134:363-374.[Abstract/Free Full Text]
23 - Sharma, J., Y. Niu, J. Ge, G. N. Pierce, and G. Zhong. 2004. Heat-inactivated C. pneumoniae organisms are not atherogenic. Mol. Cell Biochem. 260:147-152.[CrossRef][Medline]
24 - Sharma, J., Y. Zhong, F. Dong, J. M. Piper, G. Wang, and G. Zhong. 2006. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 74:1490-1499.[Abstract/Free Full Text]
25 - Shaw, A. C., B. B. Vandahl, M. R. Larsen, P. Roepstorff, K. Gevaert, J. Vandekerckhove, G. Christiansen, and S. Birkelund. 2002. Characterization of a secreted Chlamydia protease. Cell Microbiol. 4:411-424.[CrossRef][Medline]
26 - Su, H., G. McClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong. 2004. Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J. Biol. Chem. 279:9409-9416.[Abstract/Free Full Text]
27 - Subtil, A., C. Parsot, and A. Dautry-Varsat. 2001. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol. Microbiol. 39:792-800.[CrossRef][Medline]
28 - Toh, H., K. Miura, M. Shirai, and M. Hattori. 2003. In silico inference of inclusion membrane protein family in obligate intracellular parasites chlamydiae. DNA Res. 10:9-17.[Abstract]
29 - Vandahl, B. B., A. Stensballe, P. Roepstorff, G. Christiansen, and S. Birkelund. 2005. Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism. Cell Microbiol. 7:825-836.[CrossRef][Medline]
30 - Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.[Abstract/Free Full Text]
31 - Zhong, G., C. Reis e Sousa, and R. N. Germain. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94:13856-13861.[Abstract/Free Full Text]
Infection and Immunity, January 2007, p. 497-503, Vol. 75, No. 1
0019-9567/07/$08.00+0 doi:10.1128/IAI.00935-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Li, Z., Chen, D., Zhong, Y., Wang, S., Zhong, G.
(2008). The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells. Infect. Immun.
76: 3415-3428
[Abstract]
[Full Text]